Guardant Health
GH
#1190
Rank
S$25.20 B
Marketcap
S$190.07
Share price
-1.91%
Change (1 day)
234.06%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): S-$4.35

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is S-$4.37. In 2025 the company made an earnings per share (EPS) of S-$4.27 an increase over its 2024 EPS that were of S-$4.59.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.351.8%
2025S-$4.27-7.02%
2024S-$4.59-16.82%
2023S-$5.52-33.13%
2022S-$8.2660%
2021S-$5.1655.04%
2020S-$3.33207.14%
2019S-$1.08-19.81%
2018S-$1.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
S-$3.62-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S-$3.20-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA